Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Journal of Managed Care & Specialty Pharmacy
|
December 28, 2018
Implications of Removing Rosiglitazone's Black Box Warning and Restricted Access Program on the Uptake of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors Among Patients with Type 2 Diabetes
Ryan P Hickson, Ashley L Cole, Stacie B Dusetzina
European Journal of Hospital Pharmacy : Science and Practice
|
June 4, 2019
Evaluation of a pharmaceutical assessment screening tool to measure patient acuity and prioritise pharmaceutical care in a UK hospital
Ryan P Hickson, Douglas T Steinke, Charlotte Skitterall, et al.
Medical Care
|
October 13, 2021
Comparing Continuous and Binary Group-based Trajectory Modeling Using Statin Medication Adherence Data
Ryan P Hickson, Izabela E Annis, Ley A Killeya-Jones, et al.
Pharmacoepidemiology and Drug Safety
|
December 6, 2019
Opening the black box of the group-based trajectory modeling process to analyze medication adherence patterns: An example using real-world statin adherence data
Ryan P Hickson, Izabela E Annis, Ley A Killeya-Jones, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
March 15, 2024
Optimal P2Y<sub>12</sub> inhibitor durations in older men and older women following an acute myocardial infarction: A nationwide cohort study using Medicare data
Ryan P Hickson, Anna M Kucharska-Newton, Jo E Rodgers, et al.
American Journal of Infection Control
|
June 21, 2016
Clinical and economic impact of meropenem resistance in Pseudomonas aeruginosa-infected patients
William R Judd, Patrick D Ratliff, Ryan P Hickson, et al.
International Journal of Clinical Pharmacy
|
June 24, 2016
Evaluation of an alternative extended-infusion piperacillin-tazobactam dosing strategy for the treatment of gram-negative infections
Erin M Winstead, Patrick D Ratliff, Ryan P Hickson, et al.
BMJ Open
|
December 2, 2021
Disparities by sex in P2Y<sub>12</sub> inhibitor therapy duration, or differences in the balance of ischaemic-benefit and bleeding-risk clinical outcomes in older women versus comparable men following acute myocardial infarction? A P2Y<sub>12</sub> inhibitor new user retrospective cohort analysis of US Medicare claims data
Ryan P Hickson, Anna M Kucharska-Newton, Jo E Rodgers, et al.
Cancer Epidemiology
|
May 15, 2018
Review of methodological challenges in comparing the effectiveness of neoadjuvant chemotherapy versus primary debulking surgery for advanced ovarian cancer in the United States
Ashley L Cole, Anna E Austin, Ryan P Hickson, et al.
Journal of the American Heart Association
|
April 2, 2019
It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All-Cause Mortality
Ryan P Hickson, Jennifer G Robinson, Izabela E Annis, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Journal of Managed Care & Specialty Pharmacy
|
December 28, 2018
Implications of Removing Rosiglitazone's Black Box Warning and Restricted Access Program on the Uptake of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors Among Patients with Type 2 Diabetes
Ryan P Hickson, Ashley L Cole, Stacie B Dusetzina
European Journal of Hospital Pharmacy : Science and Practice
|
June 4, 2019
Evaluation of a pharmaceutical assessment screening tool to measure patient acuity and prioritise pharmaceutical care in a UK hospital
Ryan P Hickson, Douglas T Steinke, Charlotte Skitterall, et al.
Medical Care
|
October 13, 2021
Comparing Continuous and Binary Group-based Trajectory Modeling Using Statin Medication Adherence Data
Ryan P Hickson, Izabela E Annis, Ley A Killeya-Jones, et al.
Pharmacoepidemiology and Drug Safety
|
December 6, 2019
Opening the black box of the group-based trajectory modeling process to analyze medication adherence patterns: An example using real-world statin adherence data
Ryan P Hickson, Izabela E Annis, Ley A Killeya-Jones, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
March 15, 2024
Optimal P2Y<sub>12</sub> inhibitor durations in older men and older women following an acute myocardial infarction: A nationwide cohort study using Medicare data
Ryan P Hickson, Anna M Kucharska-Newton, Jo E Rodgers, et al.
American Journal of Infection Control
|
June 21, 2016
Clinical and economic impact of meropenem resistance in Pseudomonas aeruginosa-infected patients
William R Judd, Patrick D Ratliff, Ryan P Hickson, et al.
International Journal of Clinical Pharmacy
|
June 24, 2016
Evaluation of an alternative extended-infusion piperacillin-tazobactam dosing strategy for the treatment of gram-negative infections
Erin M Winstead, Patrick D Ratliff, Ryan P Hickson, et al.
BMJ Open
|
December 2, 2021
Disparities by sex in P2Y<sub>12</sub> inhibitor therapy duration, or differences in the balance of ischaemic-benefit and bleeding-risk clinical outcomes in older women versus comparable men following acute myocardial infarction? A P2Y<sub>12</sub> inhibitor new user retrospective cohort analysis of US Medicare claims data
Ryan P Hickson, Anna M Kucharska-Newton, Jo E Rodgers, et al.
Cancer Epidemiology
|
May 15, 2018
Review of methodological challenges in comparing the effectiveness of neoadjuvant chemotherapy versus primary debulking surgery for advanced ovarian cancer in the United States
Ashley L Cole, Anna E Austin, Ryan P Hickson, et al.
Journal of the American Heart Association
|
April 2, 2019
It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All-Cause Mortality
Ryan P Hickson, Jennifer G Robinson, Izabela E Annis, et al.
Page
of 2